The Abilities of Salidroside on Ameliorating Inflammation, Skewing the Imbalanced NLRP3/Autophagy and Maintaining Intestinal Barrier Are Profitable in Colitis

Liu Jiuxi,Cai Jiapei,Fan Peng,Zhang Nai-sheng,Cao Yongguo
DOI: https://doi.org/10.2139/ssrn.3436233
2019-01-01
Abstract:Salidroside (Sal), as a major glycoside extracted from Rhodiola rosea L, has exhibited its mighty anti-aging, anti-oxidant, anti-cancer, anti-inflammation and neuroprotective effects in many diseases. Whereas, it is not known whether salidroside has a protective effect on dextran sulfate sodium (DSS)-induced ulcerative colitis (UC). In this study, we investigated the protective effects and mechanisms of Sal on DSS-induced colitis in mice. The results demonstrated Sal was a competent candidate in the treatment of UC. Sal remitted DSS-induced disease activity index (DAI), colon length shortening and colonic pathological damage. Simultaneously, Sal alleviated excessive inflammation by reversing the IL-1β, TNF-α and IL-10 protein levels in DSS-treated mice. Western blot analysis revealed that Sal inhibited p65 and p38 activation together with PPARγ up-regulation. In addition, Sal skewed the imbalanced activation of NLRP3 inflammasome and autophagy contributing to colitis recovery. The damaged intestinal barrier induced by DSS was also alleviated along with plasma LPS reduction after Sal treatment.In vitro, Sal showed PPARγdependent anti-inflammatory effect in LPS-stimulated RAW264.7 cells. In summary, our results demonstrated that Sal might be an effective factor for UC treatment and its pharmacological value deserved further development. Funding Statement: This work was supported by the Key Project of Chinese National Programs for Research and Development (no. 2016YFD0501009) and National Natural Science Foundation of China (nos. 31572582 and 31472248). Declaration of Interests: The authors declare that they have no conflict of interest. Ethics Approval Statement: All animal experiments were performed in strict accordance with regulations of the Administration of Affairs Concerning Experimental Animals in China. The protocol was approved by the Institutional Animal Care and Use Committee of Jilin University (20170318).
What problem does this paper attempt to address?